Production of AirFit medical and preventive infection protection products, BioAdaptive natural vitamin complexes, and medical products

Production of medical and preventive air disinfection products and protection against respiratory infections.

Advantages of the project:

• Clinically tested with proven target effectiveness of indoor air disinfection by 95-99% and on surfaces by 99-100%, prevents cross-infection;
• Produced using special technologies for the isolation of active biocomponents based on phytoncides of wild flora.
• AirFit is hypoallergenic, stimulates the production of human's own interferon, enhances the protective functions of the immune system, and reduces the statistics of acute respiratory viral infections by 2.2 times in organized groups. Safe for all categories, including pregnant women and infants. 

Background:

• According to the World Health Organization, 40% of respiratory diseases are associated with the harmful environment of large cities, and 4 million children under the age of 5 die from acute respiratory viral infections and their complications every year. More than 33% of diseases in children under the age of 5 are caused by environmental influences and the resistance of strains of infectious agents to the action of synthesized drugs.
• In Russia, the circulation of influenza viruses and other respiratory viruses, which are transmitted by airborne droplets, is activated annually in the autumn-winter period, causing mass morbidity of the population. Influenza and acute respiratory viral infections account for up to 90-95% of the reported infectious diseases each year.